Expression of HER2 and bradykinin B1 receptors in precursor lesions of gallbladder carcinoma

World Journal of Gastroenterology

Volumn 18, Issue 11, 2012, Pages 1208-1215

  Toledo, Cesar ^a   Matus, Carola E ^a   Barraza, Ximena ^b   Arroyo, Pamela ^b   Ehrenfeld, Pamela ^a   Figueroa, Carlos D ^a   Bhoola, Kanti D ^a,c   del Pozo, Maeva ^b   Poblete, Maria T ^a,b  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b Medical School   (Chile)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Gallbladder adenoma; Gallbladder cancer; Gallbladder dysplasia; HER2; Intestinal metaplasia

Indexed keywords

BRADYKININ B1 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BASOLATERAL MEMBRANE; CARCINOMA IN SITU; CELL MEMBRANE; CELL PROLIFERATION; EPITHELIUM CELL; FEMALE; GALLBLADDER CARCINOMA; GALLBLADDER EPITHELIUM; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 84858228461     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i11.1208     Document Type: Article

References (30)

1. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-1602
2. Medina E, Kaempffer AM. Cancer mortality in Chile: epidemiological considerations. Rev Med Chil 2001; 129: 1195-1202.
3. Murakata LA, Albores-Saavedra J. Benign and malignant tumors of the gallbladder and extrahepatic biliary tract. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philadelphia: Saunders, 2004: 639-672
4. Duarte I, Llanos O, Domke H, Harz C, Valdivieso V. Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples. Cancer 1993; 72: 1878-1884
5. Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathology 2009; 55: 218-229.
6. Albores-Saavedra J, Henson DE. Gallbladder, extrahepatic bile ducts, and ampulla of Vater. In: Henson DE, AlboresSaavedra J, editors. Pathology of incipient neoplasia. Hong Kong: Oxford University Press Inc., 2001: 263-280
7. Molina L, Matus CE, Astroza A, Pavicic F, Tapia E, Toledo C, Perez JA, Nualart F, Gonzalez CB, Burgos RA, Figueroa CD, Ehrenfeld P, Poblete MT. Stimulation of the bradykinin B(1) receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway. Breast Cancer Res Treat 2009; 118: 499-510
8. Nakazawa K, Dobashi Y, Suzuki S, Fujii H, Takeda Y, Ooi A. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers. J Pathol 2005; 206: 356-365
9. Kalekou H, Miliaras D. Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma. J Gastroenterol Hepatol 2004; 19: 812-818
10. Chaube A, Tewari M, Garbyal RS, Singh U, Shukla HS. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582. BMC Cancer 2006; 6: 126
11. Kim YW, Huh SH, Park YK, Yoon TY, Lee SM, Hong SH. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas. Oncol Rep 2001; 8: 1127-1132
12. Kiguchi K, Carbajal S, Chan K, Beltrán L, Ruffino L, Shen J, Matsumoto T, Yoshimi N, DiGiovanni J. Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. Cancer Res 2001; 61: 6971-6976
13. Matsuyama S, Kitajima Y, Sumi K, Mori D, Satoh T, Miyazaki K. Gallbladder cancers rarely overexpress HER-2/neu, demonstrated by Hercep test. Oncol Rep 2004; 11: 815-819
14. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44: 1-80
15. Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005; 57: 27-77
16. Taub JS, Guo R, Leeb-Lundberg LM, Madden JF, Daaka Y. Bradykinin receptor subtype 1 expression and function in prostate cancer. Cancer Res 2003; 63: 2037-2041
17. Gera L, Stewart JM, Fortin JP, Morissette G, Marceau F. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958. Int Immunopharmacol 2008; 8: 289-292
18. Esseghir S, Reis-Filho JS, Kennedy A, James M, O'Hare MJ, Jeffery R, Poulsom R, Isacke CM. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. J Pathol 2006; 210: 420-430
19. Matus CE, Ehrenfeld P, Pavicic F, Sarmiento JM, Astroza A, Sanchez T, Salem C, Concha M, Vidal MA, Gonzalez CB, Figueroa CD. Activation of kinin B receptor triggers differentiation of cultured human keratinocytes. Br J Dermatol 2008; 159: 792-803
20. Pavelic ZP, Pavelic L, Lower EE, Gapany M, Gapany S, Barker EA, Preisler HD. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer Res 1992; 52: 2597-2602
21. Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol 1993; 170: 67-72
22. Selim AG, El-Ayat G, Wells CA. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Virchows Arch 2002; 441: 449-455
23. Walter P. Vesicular traffic in the secretory and endocytic pathways. In: Alberts B, Bray D, Lewis J, Raff M, Roberts K, Wastson JD, editors. Molecular biology of the cell. 2nd ed. New York and London: Garland Publishing Inc. 1994: 599-651
24. Ukita Y, Kato M, Terada T. Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry. J Hepatol 2002; 36: 780-785
25. van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 1988; 319: 1239-1245
26. Allred DC, O'Connell P, Fuqua SA, Osborne CK. Immuno-histochemical studies of early breast cancer evolution. Breast Cancer Res Treat 1994; 32: 13-18
27. Grabsch H, Sivakumar S, Gray S, Gabbert HE, Müller W. HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value conclusions from 924 cases of two independent series. Cell Oncol 2010; 32: 57-65
28. Ehrenfeld P, Conejeros I, Pavicic MF, Matus CE, Gonzalez CB, Quest AF, Bhoola KD, Poblete MT, Burgos RA, Figueroa CD. Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells. Cancer Lett 2011; 301: 106-118.
29. Trevisani M, Amadesi S, Schmidlin F, Poblete MT, Bardella E, Maggiore B, Harrison S, Figueroa CD, Tognetto M, Navarra G, Turini A, Bunnett NW, Geppetti P, De Giorgio R. Bradykinin B2 receptors mediate contraction in the normal and inflamed human gallbladder in vitro. Gastroenterology 2003; 125: 126-135
30. Lu DY, Leung YM, Huang SM, Wong KL. Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells. J Cell Biochem 2010; 110: 141-150